Mount Sinai Health System in New York City has announced a $6.2 million grant from the Steven & Alexandra Cohen Foundation to expand the Cohen Center for Recovery From Complex Chronic Illnesses (CoRE) to encompass research and clinical care beyond long COVID.

The expanded CoRE—which is projected to open within the coming year at The Mount Sinai Hospital on Manhattan’s Upper East Side and serve roughly 500 new patients annually—will support research to understand and highlight the key similarities and differences between long COVID; long Lyme disease/Lyme+, a collection of infection-associated chronic illnesses related to patients who were initially infected with tick- or vector-borne bacteria; and other infection-associated complex chronic illnesses. To that end, the center will offer novel, technological therapies for chronic pain, as well as personalized cognitive rehabilitation for help with cognitive impairment.

“For decades, people with long Lyme disease have struggled to find centers that can provide knowledgeable and compassionate care for their serious and debilitating symptoms,” said David Putrino, the Nash Family director of the CoRE as well as a professor of rehabilitation and human performance at the Icahn School of Medicine at Mount Sinai and director of rehabilitation innovation for the Mount Sinai Health System. “We are proud that our center will be one of the few places in the world that is embedded in a major clinical institution to provide this care—this is a patient population that has been without access to adequate care for too long.”

(Photo credit: Getty Images/Fat Camera)